Thalidomide usage in Wales: the need to follow guidelines
| Autor: | T. A. Chave, A. G. Knight, Andrew Yule Finlay |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Pregnancy test
medicine.medical_specialty Population Neural Conduction Alternative medicine Dermatology Skin Diseases Pregnancy testing Surveys and Questionnaires Humans Medicine Dermatological disorders Practice Patterns Physicians' education education.field_of_study Informed Consent Wales business.industry Peripheral Nervous System Diseases Drug Utilization Thalidomide Surgery Teratogens Family medicine Dermatologic Agents Guideline Adherence business Consent Forms Nerve conduction medicine.drug |
| Zdroj: | British Journal of Dermatology. 144:310-315 |
| ISSN: | 1365-2133 0007-0963 |
| DOI: | 10.1046/j.1365-2133.2001.04020.x |
| Popis: | BACKGROUND: Thalidomide is a potentially useful drug for several dermatological disorders. OBJECTIVES: To assess prescribing and monitoring practices for this drug in Wales. METHODS: A questionnaire was completed by 17 of 19 consultant dermatologists concerning thalidomide usage in Wales (population 2.93 million). RESULTS: Eleven of the 17 respondents had used thalidomide in 40 patients. Only two consultants gave information leaflets and only five obtained written consent. Four obtained baseline nerve conduction studies and nine obtained these during therapy. Of seven women of child-bearing age currently taking thalidomide, none had had baseline pregnancy tests. CONCLUSIONS: We describe variability in prescribing practices for thalidomide. Published guidelines are reviewed and suggestions made concerning consent forms, pregnancy testing, nerve conduction studies and patient information. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text